HAII Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
67
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$5.44M
- Investors
-
11
HAII General Information
Description
Developer of voice-based artificial intelligence (AI) technology designed to aid older people and those with mental illness. The company focuses on developing digital therapeutics, working on medicines to cure mental illnesses, such as dementia, depression, and anxiety disorder, and applying a research-evidenced AI interaction strategy, enabling patients to treat mental illness.
Contact Information
Website
www.haiiglobal.comCorporate Office
- 428, Samil-daero, Jongno-gu
- Room 501, Nagwon Arcade Building 5th Floor
- Seoul, Seoul 03140
- South Korea
Corporate Office
- 428, Samil-daero, Jongno-gu
- Room 501, Nagwon Arcade Building 5th Floor
- Seoul, Seoul 03140
- South Korea
HAII Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 23-Nov-2022 | $5.44M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 16-Sep-2020 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Nov-2017 | $529K | $529K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
HAII Patents
HAII Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026029275-A1 | Method and apparatus for evaluating neurolinguistic disorder using explainable artificial intelligence | Pending | 30-Jul-2024 | ||
| WO-2024262935-A1 | Method and device for collecting digital phenotype data | Inactive | 20-Jun-2023 | ||
| US-20240203592-A1 | Content providing method, system and computer program for performing adaptable diagnosis and treatment for mental health | Inactive | 15-Dec-2022 | ||
| WO-2024122873-A1 | Method and device for evaluating dysarthria | Inactive | 08-Dec-2022 | ||
| US-20240016442-A1 | Technique for identifying mild cognitive impairment based on gaze information | Inactive | 13-Jul-2022 | A61B5/4088 |
HAII Signals
HAII Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CJ Investment | Corporate Venture Capital | Minority | ||
| Dong Wha Pharm | Corporation | Minority | ||
| GeneN Investment Partners | Venture Capital | Minority | ||
| Lead Compass Investment | Venture Capital | Minority | ||
| Capstone Partners Korea | Venture Capital | Minority |
HAII FAQs
-
When was HAII founded?
HAII was founded in 2016.
-
Where is HAII headquartered?
HAII is headquartered in Seoul, South Korea.
-
What is the size of HAII?
HAII has 67 total employees.
-
What industry is HAII in?
HAII’s primary industry is Other Healthcare Technology Systems.
-
Is HAII a private or public company?
HAII is a Private company.
-
What is HAII’s current revenue?
The current revenue for HAII is .
-
How much funding has HAII raised over time?
HAII has raised $8.83M.
-
Who are HAII’s investors?
CJ Investment, Dong Wha Pharm, GeneN Investment Partners, Lead Compass Investment, and Capstone Partners Korea are 5 of 11 investors who have invested in HAII.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process